Agenus Inc. (AGEN) Social Stream



Agenus Inc. (AGEN): $1.88

0.03 (+1.66%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add AGEN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#309 of 381

in industry

AGENUS INC (AGEN) Price Targets From Analysts

Use the tables below to see what analysts covering AGENUS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 3 $11 $7 $9 $1.49 504.03%
2021-12-16 4 $12 $7 $10 $1.49 571.14%
2022-03-01 4 $12.001 $7 $10 $1.49 571.14%
2022-04-13 4 $14 $7 $9.666 $1.49 548.72%
2022-05-11 3 $8 $7 $7.5 $1.49 403.36%
2022-08-09 3 $8 $6 $7 $1.49 369.8%
2022-11-14 4 $8 $5 $6.333 $1.49 325.03%
2023-02-07 5 $8.3 $5 $6.825 $1.49 358.05%
2023-02-28 6 $8.3 $5 $7.06 $1.49 373.83%
2023-05-11 7 $8.3 $5 $7.06 $1.49 373.83%

The Trend in the Analyst Price Target


Over the past 27 months, AGEN's average price target has gone down $0.94.

AGEN reports an average of 231.7% for its upside potential over the past 41 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-09-28 4 8.0 5 6.333 2.20 187.86%
2022-12-22 5 8.3 5 6.825 2.56 166.6%
2023-03-28 7 8.3 5 7.060 1.48 377.03%
2023-05-10 7 8.3 5 7.060 1.54 358.44%
2023-05-11 7 8.3 5 7.060 1.40 404.29%

AGEN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.14 6 1 0 0 0 7

The Trend in the Broker Recommendations


AGEN's average broker recommendation rating worsened by 0.14 over the prior 39 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, AGENUS INC's upside potential (average analyst target price relative to current price) is higher than 1108.7% of them.
  • In the context of all US stocks, AGENUS INC's average analyst price target is greater than 99.2% of them.
  • In the context of all US stocks, AGENUS INC's number of analysts covering the stock is higher than 201.86% of them.
  • AGENUS INC's variance in analysts' estimates is lower than -231.46% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AGENUS INC are PTE, ACOR, and AIM.

Is AGEN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8485 seconds.